Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Masked, Placebo-controlled, Clinical Trial to Investigate the Efficacy of the Nutraceutical Nyaditum Resae(R) Administered to Contacts of Active Tuberculosis in Georgia.

NCT02897180 is registered in ClinicalTrials.gov with Fundació Institut Germans Trias i Pujol as lead sponsor.

NCT NCT02897180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02897180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Masked, Placebo-controlled, Clinical Trial to Investigate the Efficacy of the Nutraceutical Nyaditum Resae(R) Administered to Contacts of Active Tuberculosis in Georgia.
Lead sponsor
Fundació Institut Germans Trias i Pujol
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 10, 2017
Completion date
March 31, 2021
Enrollment
3,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

close contacts of active tuberculosis